Used in clinical and research laboratories to detect and quantify neutrophil gelatinase-associated lipocalin (NGAL), a biomarker for early kidney injury. The kit enables rapid assessment of NGAL levels in human biological samples such as serum, plasma, and urine. It is widely applied in studies related to acute kidney injury (AKI), chronic kidney disease, sepsis, and post-operative renal function monitoring. Due to its high sensitivity and specificity, this ELISA kit supports early diagnosis, disease progression tracking, and evaluation of therapeutic responses in renal and inflammatory conditions. It is also used in cardiovascular and metabolic research where NGAL expression is elevated.